药品
医学
肝损伤
对乙酰氨基酚
疾病
重症监护医学
肝病
药物开发
药理学
内科学
出处
期刊:Elsevier eBooks
[Elsevier BV]
日期:2017-01-01
卷期号:: 204-216
标识
DOI:10.1016/b978-0-12-409547-2.12382-0
摘要
Drug-induced liver disease or drug-induced liver injury (DILI) is a rare but serious complication of drug treatment. DILI may be concentration-dependent; an example is potentially fatal liver failure from acetaminophen overdose. However, some commonly prescribed drugs, especially antimicrobials, may cause idiosyncratic DILI when used at the recommended dose. The underlying mechanism for idiosyncratic DILI is poorly understood. Methods to determine potential for new drugs to cause idiosyncratic DILI during development exist but need improvement. Risk factors for idiosyncratic DILI include age, gender, drug–drug interactions, and genetics. Studies to predict individual susceptibility to idiosyncratic DILI are in progress.
科研通智能强力驱动
Strongly Powered by AbleSci AI